Synergetics USA, Inc. (NASDAQ:SURG)
CAPS Rating:
The Company designs, manufactures and markets precision-engineered, microsurgical instruments, capital equipment and devices primarily for use in vitreoretinal surgery and neurosurgical applications.
RSS Headlines
Fool UK
Recs
Profitable with 20% projected growth and no debt. Pop today on analyst upgrade, should keep going up.